Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China CROs Step Out Into The World

This article was originally published in PharmAsia News

Executive Summary

Recent activities by China's leading contract research organizations - Wuxi Pharma's acquisition of U.S.-based AppTec laboratory services, joint ventures between Rundo and Japanese Cronova as well as Medicilon and U.S. firm MPI Research - signal that local Chinese corporations are ready to forge closer partnerships with overseas enterprises to boost their technology. In addition, such cooperation will help facilitate the partners entering each other's market. At present, no Chinese CRO has yet met international good laboratory practices standards owing to a lack of specialized talents to set up and manage GLP laboratories. Analysts say that local CROs must meet international technology standards and close the gap with large multinational CROs to enhance their competitiveness in a global market. (Click here for more)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts